N-acetylcysteine in the prevention of contrast agent-induced nephrotoxicity in patients undergoing computed tomography studies

Therapy

Volumn 3, Issue 6, 2006, Pages 773-777

  Khalili, Hossein ^a   Dashti Khavidaki, Simin ^a   Tabifar, Hamed ^a   Ahmadinejad, Nasrin ^b   Ahmadi, Farrokhlegha ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; Contrast agent induced; N acetylcysteine; Nephrotoxicity

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; CREATININE; IOHEXOL; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE CLEARANCE; DEMOGRAPHY; DRUG EFFICACY; FEMALE; FLUID THERAPY; FOLLOW UP; HUMAN; HYDRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PROPHYLAXIS; RISK FACTOR; SIDE EFFECT; SINGLE DRUG DOSE;

EID: 33845417019     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.1586/14750708.3.6.773     Document Type: Article

References (18)

1. Nash K, Hafeez A, Hou S. Hospital acquired renal insufficiency. Am. J. Kidney Dis. 39(5), 930-936 (2002).
2. Davidson CJ, Laskey WK, Hermiller JB et al. Randomized trial of contrast media utilization in high-risk PTCA. The COURT trial. Circulation 101, 2172-2177 (2000).
3. Russo D, Minutolo R, Cianciarus, Memoli B, Conte G, De Nicola L. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J. Am. Soc. Nephrol. 6, 1451-1458 (1995).
4. Tepel M, Van Der Giet M, Schwarzfeld C, Lauler U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N. Engl. J. Med. 343(3), 180-184 (2000).
5. Morcos SK. Contrast media-induced nephrotoxicity - questions and answers. Br. J. Radiol. 71, 357-365 (1998).
6. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N. Engl. J. Med. 331(21), 1416-1420 (1994).
7. Briguori C, Colombo A, Airoldi F et al. N-acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J. Am. Coll. Cardiol. 44(4), 762-765 (2004).
8. Briguori C, Colombo A, Violante A et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent induced nephrotoxicity. Eur. Heart J. 25, 206-211 (2004).
9. Marenzi G, Assanelli E, Marana I et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N. Engl. J. Med. 354(26), 2773-2782 (2006).
10. Briguori C, Mangandelli F, Pierfranco S et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J. Am. Coll. Cardiol. 40(2), 298-303 (2002).
11. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am. J. Med. 103, 368-375 (1997).
12. Rudnick MR, Goldfarb S, Wexler L et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 47(1), 254-261 (1995).
13. Briguori C, Colombo A, Airoldi F et al. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Kidney Int. 68(5), 2250-2255 (2005).
14. El Mahmoud R, Le Feuvre C, Le Quan Sang KH et al. Absence of nephroprotective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography. Arch. Mal. Coeur Vaiss. 96(12), 1157-1161 (2003).
15. Sandhu C, Belli AM, Oliveira DB. The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity. Cardiovasc. Intervent. Radiol. 29(3), 344-347 (2006).
16. Brick R, Krzossok S, Markowetz F, Schnulle P, Van Der Woude FJ, Braun C. Acetyl cysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362, 598-603 (2003).
17. Allonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ. Prevention of radiocontrast nephropathy with N-acetylcysteine in patient with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am. J. Kidney Dis. 43, 1-9 (2004).
18. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int. 65, 1366-1374 (2004).